Valuation: SciBase Holding AB

Market Cap 35Cr 3.59Cr 3.16Cr 2.93Cr 2.7Cr 5.06Cr 347.64Cr 5.15Cr 14Cr 169.56Cr 13Cr 13Cr 588.26Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 35Cr 3.59Cr 3.16Cr 2.93Cr 2.7Cr 5.06Cr 347.64Cr 5.15Cr 14Cr 169.56Cr 13Cr 13Cr 588.26Cr EV / Sales 2026 *
5.32x
EV / Sales 2027 * 3.37x
Free-Float
77.17%
Yield 2026 *
-
Yield 2027 * -
1 day+3.63%
1 week-2.56%
Current month+5.54%
1 month+4.57%
3 months-16.34%
6 months+54.50%
Current year-0.58%
1 week 32
Extreme 32
35.3
1 month 29.65
Extreme 29.65
37
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
148.4
5 years 18.5
Extreme 18.5
657
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 16/05/2017
Chairman 66 13/06/2024
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%-2.56%-7.30%-70.38% 3.59Cr
-0.41%-8.79%+14.70%-38.13% 1.56TCr
+9.95%+6.85%+9.30%+115.26% 178.69Cr
+1.36%-9.10%-37.67%-80.94% 113.06Cr
-2.56%-5.81%-38.88%+9.93% 96Cr
+0.57%-6.27%-29.58%-53.93% 63Cr
+2.48%-10.19%-47.94%-56.93% 52Cr
+0.37%-0.37%+39.40%-53.79% 45Cr
+0.84%-5.25%-57.58%-62.05% 36Cr
+0.29%-5.71%-22.28%-39.78% 34Cr
Average +1.60%-2.32%-17.78%-33.08% 218.39Cr
Weighted average by Cap. +0.55%-7.06%+5.14%-27.38%

Financials

2026 *2027 *
Net sales 6.59Cr 67.45L 59.32L 55.11L 50.69L 95.05L 65Cr 96.76L 2.57Cr 32Cr 2.53Cr 2.48Cr 110.53Cr 10Cr 1.07Cr 93.8L 87.14L 80.14L 1.5Cr 103.28Cr 1.53Cr 4.06Cr 50Cr 4Cr 3.92Cr 174.77Cr
Net income -6.63Cr -67.86L -59.68L -55.44L -50.99L -95.63L -66Cr -97.34L -2.59Cr -32Cr -2.55Cr -2.49Cr -111.2Cr -5.15Cr -52.71L -46.36L -43.07L -39.61L -74.28L -51Cr -75.61L -2.01Cr -25Cr -1.98Cr -1.94Cr -86Cr
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
23/26/23 SEK 34.30 +3.63% 1,551
22/26/22 SEK 33.10 -4.06% 3,611
21/26/21 SEK 34.50 -2.27% 90
20/26/20 SEK 35.30 0.00% 44
17/26/17 SEK 35.30 +0.28% 2,057

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock